Letters by company

Boule Diagnostics AB (publ)

1 letter discussing BDABF. Everything written about it on this site is on its ticker page.

Protean Funds Paper Profits, Pulp Fiction Protean Funds shorted Holmen, arguing that Nordic pulp and paper economics face eucalyptus competition, rising wood costs, climate-related forestry risks and an unsustainable ESG premium. Protean Small Cap added Arctic Falls and Afry, tendered Addvise and sold Nilfisk after takeover bids, while the firm considers a low-fee global Aktiesparfond. December 2025 HLMNY $4.9BARFA $59M